Conference abstract
Enhanced immunity in intradermal vaccination by novel hollow microneedles
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Background & Objective: We have developed a new device with multiple fine needles fabricated with a bevel angle to release a drug broadly and homogeneously into the skin in a horizontal fashion and reported in the article. It led us to develop another type of multiple needles to release a drug in the epidermis or upper dermis. The intradermal (ID) route for vaccination represents an effective alternative to subcutaneous (SC)/intramuscular administration to induce protective immunity. However, a critical issue associated with ID vaccination is the precise delivery of solution in the upper dermis, which ensures enhanced immunity. Methods: We fabricated a hollow microneedle unit made of poly-glycolic acid by injection molding and bonding and developed a dedicated prototype injector. To ensure ID delivery of solution, the injected site was macroscopically and microscopically examined. Serum immunoglobulin G antibody production was measured by enzyme immunoassay and compared in groups of rats following either ID delivery with microneedles or SC administration with a 27-G stainless needle of graded vaccine doses. Results: The unit used a tandem array of six microneedles, each with a side delivery hole, and a conduit inside for solution. Microneedles installed in the injector punctured at the skin with the aid of a spring. Injection of solution formed a wheal due to ID distribution. Histologically, a wedge-shaped skin defect in the upper skin corresponded to each puncture site. Antibody titers following vaccinations on days one and eight were significantly higher with ID injection than with SC delivery on day 15 and every seven days, thereafter until day 36 with mumps vaccination, and until day 36 with varicella vaccination. Conclusions: The microneedle unit presented here delivered solution intradermally without any difficulty and evoked antibody responses against viruses even with the reduced vaccine volume. Our findings confirm promising results of ID delivery as an immunogenic option to enhance vaccination efficacy.
Keywords
Subjects
Pharmaceutical SciencesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalPharmaceutica Analytica Acta
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “Hidekazu Fukamizu”
- BylineArticles whose byline prints “Noriyuki Ogai”
- BylineArticles whose byline prints “Isamu Nonaka”
- BylineArticles whose byline prints “Yasuhiro Toda”
- BylineArticles whose byline prints “Takahisa Ono”
- BylineArticles whose byline prints “Shinji Minegishi”
- BylineArticles whose byline prints “Akinori Inou”
- BylineArticles whose byline prints “Masahiko Hachiya”
